Diabetes and ischemic stroke are two major causes of mortality and morbidity. They are also very costly and impair quality of life.
The study is part of the Finnish Diabetic Nephropathy (FinnDiane) Study, a nationwide multicenter study aiming to identify risk factors for diabetic vascular complications, without a history of overt cerebrovascular disease.
The goal of this study is to characterize, by brain MRI and cognitive testing, and find causal risk factors for cerebrovascular changes and events in patients with T1D. The aim is to identify patients at risk in order to plan their prevention and treatment individually to eventually delay or even prevent cerebrovascular morbidity and mortality diabetes. While succeeding this will not only improve quality of life of the patients but also reduce costs for the healthcare system and the entire society.